Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Bubs Australia Ltd. ( (AU:BUB) ) has provided an update.
Bubs Australia Ltd. has announced a change in the director’s interest, with Mr. Joseph Coote acquiring 7,132,645 performance rights under the company’s Employee Rights Plan. This issuance, approved by shareholders at the AGM, reflects the company’s strategy to align executive incentives with shareholder interests, potentially impacting the company’s governance and operational focus.
The most recent analyst rating on (AU:BUB) stock is a Buy with a A$0.18 price target. To see the full list of analyst forecasts on Bubs Australia Ltd. stock, see the AU:BUB Stock Forecast page.
More about Bubs Australia Ltd.
Bubs Australia Ltd. operates in the infant nutrition industry, primarily focusing on producing and distributing infant formula and related nutritional products. The company is known for its commitment to providing high-quality, safe, and nutritious products for infants and toddlers, catering to both domestic and international markets.
Average Trading Volume: 1,875,989
Technical Sentiment Signal: Sell
Current Market Cap: A$125.2M
For detailed information about BUB stock, go to TipRanks’ Stock Analysis page.